News | January 27, 2011

ASTRO Reaffirms Commitment to Quality, Patient Safety Plan

January 27, 2011 – The American Society for Radiation Oncology (ASTRO) is continuing its commitment to Target Safely, a six-point patient protection plan developed in January 2010. The plan is designed to improve the safety and quality of radiation therapy treatments and reduce the chances of medical errors.

"Dealing with a cancer diagnosis is hard enough for patients without having the additional burden of worrying about the accuracy and safety of their treatments," said Anthony L. Zietman, M.D., ASTRO chairman and a radiation oncologist at Massachusetts General Hospital in Boston. "With every cancer patient, the goal is to treat and/or cure his or her disease in the safest and most effective way possible, that's why ASTRO is focused completely on ensuring patient safety."

Since the plan was established, ASTRO has made great strides in its Target Safely goals. Over the past year, ASTRO has:

• Proposed federal legislation to develop a national medical error reporting system and a patient safety database for radiation oncology.

• Tested the compatibility of different radiation oncology equipment vendors. Four use cases, or interoperability problems, were tested and passed successfully. Integrating the Healthcare Enterprise – Radiation Oncology (IHE-RO) is an ASTRO-sponsored initiative dedicated to improving integration issues related to radiation treatment equipment. Problems submitted to IHE-RO are reviewed by a taskforce composed of vendors, physicists and clinicians and taken directly to vendors. ASTRO is asking all radiation oncologists and hospitals to consider only IHE-RO compliant technologies when selecting new radiation therapy equipment.

• Continued to strengthen radiation oncology practice accreditation with more robust and meaningful measures. We are encouraging all radiation oncologists to participate.

• Made progress toward passage of legislation to require licensing standards for personnel performing radiation treatments, known as the CARE Act.

• Worked with patient support groups, cancer survivors and other medical organizations to create a list of questions patients should ask their physicians and cancer centers when considering radiation therapy as a treatment for their disease. These are designed to help patients better understand the safety checks and balances that are put into place to guard against errors. Those questions are available for download on rtanswers.org and to view as videos posted on YouTube.

• Developed a free self-assessment module titled "Quality Assurance for Advanced Technology Radiation Therapy" to review and identify quality assurance processes for all ASTRO members.

• Committed to incorporating quality and safety educational content in all ASTRO meetings to ensure attendees have the resources necessary to provide safe and effective patient care.

"Any error is one error too many," Zietman said. "We will remain devoted to these Target Safely goals until the possibility of error is eliminated."

For more information: www.astro.org/TargetSafely

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
Overlay Init